{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T12:09:11Z","timestamp":1774008551831,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T00:00:00Z","timestamp":1452643200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s10067-015-3167-8","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T01:19:26Z","timestamp":1452647966000},"page":"663-666","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study"],"prefix":"10.1007","volume":"35","author":[{"given":"Ekin Oktay","family":"Oguz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhan","family":"Kucuksahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Turgay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa Turgut","family":"Yildizgoren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Askin","family":"Ates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nalan","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem Ozdemir","family":"Kumbasar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulay","family":"Kinikli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nursen","family":"Duzgun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,13]]},"reference":[{"key":"3167_CR1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.iac.2012.09.002","volume":"32","author":"AL Olson","year":"2012","unstructured":"Olson AL, Brown KK, Fischer A (2012) Connective tissue disease-associated lung disease. Immunol Allergy Clin North Am 32:513\u2013536","journal-title":"Immunol Allergy Clin North Am"},{"issue":"32","key":"3167_CR2","first-page":"2","volume":"22","author":"A Fischer","year":"2015","unstructured":"Fischer A, Chartrand S (2015) Assessment and management of connective tissue disease-associated interstitial lung disease. Sarcoidosis Vasc Diffuse Lung Dis 22(32):2\u201321","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"3167_CR3","first-page":"151","volume":"46","author":"N Kohno","year":"1999","unstructured":"Kohno N (1999) (1999) Serum marker KL-6\/MUC1 for the diagnosis and management of interstitial pneumonitis. J Med Invest 46:151\u2013158","journal-title":"J Med Invest"},{"key":"3167_CR4","doi-asserted-by":"crossref","unstructured":"Hu Y, Wang LS, Jin YP, et al. (2015) Serum Krebs von den Lungen-6 level as a diagnostic biomarker for interstitial lung disease in Chinese patients. Clin Respir J. doi: 10.1111\/crj.12341. [Epub ahead of print]","DOI":"10.1111\/crj.12341"},{"key":"3167_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.resinv.2012.02.001","volume":"50","author":"N Ishikawa","year":"2012","unstructured":"Ishikawa N, Hattori N, Yokoyama A et al (2012) Utility of KL-6\/MUC1 in the clinical management of interstitial lung diseases. Respir Inverstig 50:3\u201313","journal-title":"Respir Inverstig"},{"key":"3167_CR6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-0034-1371527","volume":"35","author":"F Bonella","year":"2014","unstructured":"Bonella F, Costabel U (2014) Biomarkers in connective tissue disease-associated interstitial lung disease. Semin Respir Crit Care Med 35:181\u2013200","journal-title":"Semin Respir Crit Care Med"},{"key":"3167_CR7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1378\/chest.108.2.311","volume":"108","author":"J Kobayashi","year":"1995","unstructured":"Kobayashi J, Kitamura S (1995) KL-6: a serum marker for interstitial pneumonia. Chest 108:311\u2013315","journal-title":"Chest"},{"key":"3167_CR8","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1378\/chest.109.5.1276","volume":"109","author":"J Kobayashi","year":"1996","unstructured":"Kobayashi J, Kitamura S (1996) Serum KL-6 for the evaluation of active pneumonitis in pulmonary sarcoidosis. Chest 109:1276\u201382","journal-title":"Chest"},{"key":"3167_CR9","first-page":"429","volume":"21","author":"K Yanaba","year":"2003","unstructured":"Yanaba K, Hasegawa M, Hamaguchi Y et al (2003) Longitudinal analysis of serum KL-6 levels in patients with systemic sclerosis: association with the activity of pulmonary fibrosis. Clin Exp Rheumatol 21:429\u2013436","journal-title":"Clin Exp Rheumatol"},{"key":"3167_CR10","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.2169\/internalmedicine.50.5866","volume":"50","author":"S Doishita","year":"2011","unstructured":"Doishita S, Inokuma S, Asashima H et al (2011) Serum KL-6 level as an indicator of active or inactive interstitial pneumonitis associated with connective tissue diseases. Intern Med 50:2889\u20132892","journal-title":"Intern Med"},{"key":"3167_CR11","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1164\/ajrccm.165.3.2107134","volume":"165","author":"H Ohnishi","year":"2002","unstructured":"Ohnishi H, Yokoyama A, Kondo K et al (2002) Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med 165:378\u2013381","journal-title":"Am J Respir Crit Care Med"},{"key":"3167_CR12","first-page":"930","volume":"27","author":"K Yamane","year":"2000","unstructured":"Yamane K, Ihn H, Kubo M et al (2000) Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis. J Rheumatol 27:930\u2013934","journal-title":"J Rheumatol"},{"key":"3167_CR13","first-page":"27","volume":"28","author":"F Bonella","year":"2011","unstructured":"Bonella F, Volpe A, Caramaschi P et al (2011) Surfactant protein D and KL-6 serum levels in systemic sclerosis: correlation with lung and systemic involvement. Sarcoidosis Vasc Diffuse Lung Dis 28:27\u201333","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"3167_CR14","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.bbrc.2005.10.144","volume":"338","author":"S Ohshimo","year":"2005","unstructured":"Ohshimo S, Yokoyama A, Hattori N et al (2005) KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts. Biochem Biophys Res Commun 338:1845\u20131852","journal-title":"Biochem Biophys Res Commun"},{"key":"3167_CR15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2466-11-22","volume":"11","author":"N Ishikawa","year":"2011","unstructured":"Ishikawa N, Mazur W, Toljamo T et al (2011) Ageing and long term smoking affects KL-6 levels in the lung, induced sputum and plasma. BMC Pulm Med 11:22","journal-title":"BMC Pulm Med"},{"key":"3167_CR16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/BF02982094","volume":"74","author":"T Ashida","year":"2001","unstructured":"Ashida T, Higashishiba M, Sumimoto Y et al (2001) Serum KL-6 levels in patients with pulmonary complications after allogeneic bone marrow transplantation. Int J Hematol 74:464\u2013468","journal-title":"Int J Hematol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-3167-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-015-3167-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-3167-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T10:44:20Z","timestamp":1567507460000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-015-3167-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,13]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["3167"],"URL":"https:\/\/doi.org\/10.1007\/s10067-015-3167-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,13]]}}}